Brief: Kuros Biosciences H1 Net Loss At CHF 5.2 Mln
Sept 5 (Reuters) - KUROS BIOSCIENCES AG KURN.S :
* H1 NET LOSS AMOUNTS TO CHF 5.2 MILLION, COMPARED TO CHF
7.0
MILLION IN CORRESPONDING PERIOD IN FIRST HALF OF 2017
* H1 REVENUES AMOUNTED TO CHF 0.3 MILLION (FIRST HALF 2017:
CHF
0.5 MILLION)
Source text for Eikon: ID:nTEN4re7ia
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million